Nippon India Pharma Fund
Equity
●
Pharma & Health Care
Fund Details
- Expense Ratio: A charge to the mutual fund for handling your investments. It's a percentage of the fund's assets used for various expenses like administration and management.
- Exit Load : A fee paid to a mutual fund for leaving the investment early before a set period
- Lock In : Withdrawals are not allowed for this period
Current NAV
₹485.27
Expense Ratio
1.81%
Min SIP
₹100
Fund Size
₹8306Cr
Min Investment
₹5.00K
Lock In
NA
Scheme Information Document
Exit load: 1% on or before 1M, Nil after 1M
Fund Performance
- Alpha: Excess returns relative to market benchmark,
- Beta : Volatility of the scheme relative to its market benchmark
- Sharpe Ratio : Risk-adjusted returns
- Risk : Volatility of the fund
Alpha
-0.04%
Beta
0.92
Sharpe Ratio
0.34454
Risk
21.43%
Above numbers are based upon past 3 years
Returns Calculator
Would have become
₹1,49,748.59
(1.72)%
| Name | Holding(%) |
| Name | Sector(%) |
| Name | Assets(%) |
- Bajaj Finserv Healthcare Fund
- Kotak Healthcare Fund
- HDFC Pharma and Healthcare Fund
- Bandhan Healthcare Fund
- Aditya Birla Sun Life Pharma & Healthcare Fund
- PGIM India Healthcare Fund
- DSP Healthcare Fund
- Quant Healthcare Fund
- Nippon India Pharma Fund
- LIC MF Healthcare Fund
- Mirae Asset Healthcare Fund
- SBI Healthcare Opportunities Fund
- ITI Pharma & Healthcare Fund
- Tata India Pharma & Healthcare Fund
- WhiteOak Capital Pharma and Healthcare Fund
- ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
- Baroda BNP Paribas Health and Wellness Fund
- UTI Healthcare Fund
Sailesh Raj Bhan
Nippon India Mutual FundTotal assets under management
₹573.67L Crores
Date of incorporation
24 Feb 1995
Nippon India Pharma Fund FAQs
Ans.
- Open the Rupeezy app.
- If you're on the Stocks or F&O screen, switch to the Mutual Funds section.
- Tap on Explore to browse available mutual fund schemes.
- Select the Nippon India Pharma Fund (or any fund you want to invest in).
- Choose your investment mode: Lumpsum or SIP.
- Enter the investment amount.
- Complete the payment using UPI, Net Banking, or other available options.
Ans. The Nippon India Pharma Fund has an AUM of ₹8306.35 Cr as on 4/2/2026. The scheme has delivered CAGR returns for the past 3 years against a category average of 21.66%. The risk is Very High against the category average of 80.05.
Ans. Mutual fund taxation depends on the scheme type and investment holding period.
Taxation on equity funds: For equity funds (funds that invest at least 65% of the corpus in Indian stocks), if the holding period is more than 12 months, LTCG (Long Term Capital Gains) tax is applicable. For units sold within 12 months of purchase, STCG (Short Term Capital Gains) Tax is applicable.
LTCG tax on equity-oriented schemes is 12.5% on capital gains over ₹1.25 lakh (as per the latest update in Budget 2024).
STCG tax applicable on the sale of units of equity-oriented mutual fund schemes is 20%.
Ans. There is no lock-in period applicable on Nippon India Pharma Fund.
Ans. The expense ratio of Nippon India Pharma Fund is 1.81%.